SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GRAZI, Gian Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.883
AS - Asia 5.205
EU - Europa 1.729
SA - Sud America 1.365
Continente sconosciuto - Info sul continente non disponibili 522
AF - Africa 156
OC - Oceania 12
Totale 15.872
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.527
SG - Singapore 2.174
BR - Brasile 1.034
CN - Cina 770
HK - Hong Kong 600
IT - Italia 547
VN - Vietnam 540
BD - Bangladesh 343
FI - Finlandia 227
RU - Federazione Russa 204
ID - Indonesia 186
JP - Giappone 176
FR - Francia 172
DE - Germania 153
CA - Canada 150
GB - Regno Unito 143
IN - India 114
AR - Argentina 104
MX - Messico 101
UA - Ucraina 59
CO - Colombia 58
EC - Ecuador 55
NL - Olanda 54
TR - Turchia 53
ZA - Sudafrica 51
AT - Austria 48
IQ - Iraq 40
CL - Cile 32
VE - Venezuela 30
PK - Pakistan 28
PY - Paraguay 27
SE - Svezia 25
ES - Italia 24
MA - Marocco 23
SA - Arabia Saudita 23
JM - Giamaica 22
MY - Malesia 22
UZ - Uzbekistan 20
KE - Kenya 18
PH - Filippine 17
CR - Costa Rica 16
DZ - Algeria 15
TN - Tunisia 13
TT - Trinidad e Tobago 13
AE - Emirati Arabi Uniti 10
AZ - Azerbaigian 10
DO - Repubblica Dominicana 10
PE - Perù 10
AU - Australia 9
JO - Giordania 9
NP - Nepal 9
BO - Bolivia 8
CH - Svizzera 8
EG - Egitto 8
HN - Honduras 8
LT - Lituania 8
PL - Polonia 8
IE - Irlanda 7
UY - Uruguay 7
AL - Albania 6
BH - Bahrain 6
IL - Israele 6
KR - Corea 6
KZ - Kazakistan 6
SV - El Salvador 6
TW - Taiwan 6
BY - Bielorussia 5
ET - Etiopia 5
SN - Senegal 5
BE - Belgio 4
NI - Nicaragua 4
OM - Oman 4
BB - Barbados 3
DK - Danimarca 3
EE - Estonia 3
GT - Guatemala 3
KW - Kuwait 3
LB - Libano 3
MO - Macao, regione amministrativa speciale della Cina 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
TH - Thailandia 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BS - Bahamas 2
CZ - Repubblica Ceca 2
EU - Europa 2
GP - Guadalupe 2
GR - Grecia 2
HT - Haiti 2
HU - Ungheria 2
IR - Iran 2
LC - Santa Lucia 2
LV - Lettonia 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
Totale 15.316
Salva come PNG Salva come JPEG
Città #
Singapore 1.138
Ashburn 880
San Jose 879
Santa Clara 823
Hong Kong 597
Council Bluffs 520
Fairfield 274
Beijing 273
Helsinki 219
Ho Chi Minh City 191
Tokyo 171
Chandler 165
New York 149
Lauterbourg 148
Jakarta 133
Hanoi 123
Houston 115
Woodbridge 103
Los Angeles 91
São Paulo 83
Dallas 76
Seattle 76
Wilmington 75
Princeton 72
Mexico City 71
Toronto 70
Chicago 69
Milan 69
Rome 60
Cambridge 58
Moscow 57
Orem 48
Boardman 46
San Diego 46
London 43
Nuremberg 42
Shanghai 41
Ann Arbor 40
Buffalo 33
Rio de Janeiro 32
Brasília 27
Jacksonville 25
Haiphong 23
Salt Lake City 23
Vienna 23
Baghdad 22
Brooklyn 22
Quito 22
Belo Horizonte 21
Montreal 21
San Francisco 21
Chennai 20
Da Nang 20
Bologna 19
Curitiba 19
Medellín 19
Frankfurt am Main 18
Guangzhou 18
Naples 18
Porto Alegre 18
Tashkent 18
Atlanta 17
Newark 17
Portsmouth 17
Biên Hòa 16
Falkenstein 16
Falls Church 16
Caracas 15
Ferrara 14
Fortaleza 14
Guayaquil 14
Nairobi 14
Turin 14
Dhaka 13
Istanbul 13
Johannesburg 13
Manchester 13
Mumbai 13
Phoenix 13
Tampa 13
Washington 13
Bari 12
Guarulhos 12
San José 12
Buenos Aires 11
Kingston 11
Philadelphia 11
Amsterdam 10
Asunción 10
Campinas 10
Charlotte 10
Hangzhou 10
Kuala Lumpur 10
Queens 10
Salvador 10
Santiago 10
Amman 9
Ankara 9
Austin 9
Baku 9
Totale 9.119
Salva come PNG Salva come JPEG
Nome #
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 210
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 184
Tumor Regression Grade After Neoadjuvant Chemoradiation and Surgery for Low Rectal Cancer Evaluated by Multiple Correspondence Analysis: Ten Years as Minimum Follow-up 179
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 173
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics 169
The Immune Landscape of Cancer 160
A case report of giant hepatic hemangioma spontaneous regression in adult, non-cirrhotic patient and literature review 153
Oncogenic Signaling Pathways in The Cancer Genome Atlas 149
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis 148
A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples 141
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma 140
Early onset aggressive hereditary amyloidosis: report of an Italian family with TTR Arg47 mutation. 137
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers 137
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily 125
ALPPS for primary and secondary liver tumors 124
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation 124
Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry 124
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer 121
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics 117
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines 117
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas 114
Comprehensive Characterization of Cancer Driver Genes and Mutations 114
Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma 112
Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparison 112
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation 110
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer 108
Genomic and Functional Approaches to Understanding Cancer Aneuploidy 106
Pathogenic Germline Variants in 10,389 Adult Cancers 106
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 104
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 103
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients 102
Genetically driven CD39 expression shapes human tumor-infiltrating CD8+ T-cell functions 102
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma 102
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 102
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system 100
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation 99
Wnt3a/b-Catenin signaling conditions differentiation of partially exhausted T-effector cells in human cancers 99
Hepatocellular carcinoma surgical and oncological trends in a national multicentric population: the HERCOLES experience 98
Renewed considerations on the utility (or the futility) of hepatic resections for breast cancer liver metastases 98
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria 96
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma 96
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 96
The Impact of Hospital Volume on Failure to Rescue after Liver Resection for Hepatocellular Carcinoma: Analysis from the HE.RC.O.LE.S. Italian Registry 94
Laboratory test variability and Model for End-Stage Liver Disease score calculation: effect on liver allocation and proposal for adjustment 93
The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma 93
Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells 93
Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study 93
Primary leiomyoma of the liver in an immunocompetent patient 92
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis 92
Forcing ATGL expression in hepatocarcinoma cells imposes glycolytic rewiring through PPAR-α/p300-mediated acetylation of p53 91
The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancer/stromal cell cooperation 91
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period 90
Evolution of pancreatectomy with en bloc venous resection for pancreatic cancer in Italy. Retrospective cohort study on 425 cases in 10 pancreatic referral units 90
Key components of a hepatobiliary surgery curriculum for general surgery residents: results of the FULCRUM International Delphi consensus 88
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer 88
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas 88
Down-staging of hepatocellular carcinoma prior to liver transplantation: the power of selection 88
Current status of liver surgery for non-colorectal non-neuroendocrine liver metastases: the NON.LI.MET. Italian Society for Endoscopic Surgery and New Technologies (SICE) and Association of Italian Surgeons in Europe (ACIE) collaborative international survey 87
The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome 87
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study 87
Multiple hepatocellular carcinoma: Long-term outcomes following resection beyond actual guidelines. An Italian multicentric retrospective study 86
Association of polygenic risk score and bacterial toxins at screening colonoscopy with colorectal cancer progression: A multicenter case-control study 85
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population 84
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases 84
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients 84
Liver resection for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis of risk factors for intrahepatic recurrence 83
Efficacy of MELD score in predicting survival after liver retransplantation 83
Multicohort and cross-platform validation of a prognostic Wnt signature in colorectal cancer 83
Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 83
FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma 83
Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years 82
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 81
Impact of a goal-directed fluid therapy on length of hospital stay and costs of hepatobiliarypancreatic surgery: A prospective observational study 81
Benchmarking postoperative outcomes after open liver surgery for cirrhotic patients with hepatocellular carcinoma in a national cohort 81
Multicentre evaluation of case volume in minimally invasive hepatectomy 80
Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery 80
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation 79
Psychological Adaptation and Quality of Life of Adult Intestinal Transplant Recipients: University of Bologna Experience 79
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 77
Outcome of Right Hepatectomies in Patients Older Than 70 Years 77
Molecular Aging of Human Liver: An Epigenetic/Transcriptomic Signature 76
Long Term Follow-Up of Patients with De Novo Tumors after 1300 Liver Transplantations: A Case-Control Study 76
Improving the outcome of liver transplantation with very old donors with updated selection and management criteria 76
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma 75
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? 75
Robotic Liver Resections: Application of Difficulty Score Systems to an Initial Experience. Is a Specific Robotic Difficulty Score Necessary? 75
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 75
Recommendations for management of patients with neuroendocrine liver metastases 74
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era 74
Blood transfusions and steatohepatitis are independent risk factors for complications following liver resection for colorectal cancer liver metastases 74
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 74
The largest western experience on salvage hepatectomy for recurrent hepatocellular carcinoma: propensity score-matched analysis on behalf of He.RC.O.Le.Study Group 74
The peculiar aging of human liver: A geroscience perspective within transplant context 73
Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: An emerging fungal agent 72
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation 72
Coping strategies in intestinal transplantation 72
A bioluminescent mouse model of proliferation to highlight early stages of pancreatic cancer: A suitable tool for preclinical studies 71
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience 71
Sustained virological response to antiviral therapy in a randomized trial of cyclosporine versus tacrolimus in liver transplant patients with recurrent hepatitis C infection 71
Is it time to develop a robotic difficulty score system? 71
Totale 9.942
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.579
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.579
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022500 0 0 7 6 13 11 127 73 41 22 58 142
2022/2023798 75 45 8 50 46 398 9 41 64 4 35 23
2023/2024498 38 79 38 22 24 18 14 19 19 8 30 189
2024/20253.203 115 49 326 3 378 394 59 129 402 838 238 272
2025/20268.560 467 344 853 1.016 934 318 679 507 1.024 1.285 590 543
2026/20271.538 422 613 503 0 0 0 0 0 0 0 0 0
Totale 15.872